Navigation Links
Rib-X Pharmaceuticals Receives Award from NIAID to Develop Antibiotic Treatment for Gonorrhea
Date:9/14/2009

nfections."

About Delafloxacin

Delafloxacin, a novel, broad spectrum, next-generation fluoroquinolone, has demonstrated better activity than other quinolones against Gram-positive bacteria, including isolates of MRSA that are quinolone-resistant. Recently, Rib-X has announced positive results from a Phase 2 trial utilizing the IV formulation of delafloxacin in complicated skin and skin structure infections (cSSSI). Delafloxacin successfully completed two previous Phase 2 trials with the oral formulation. In microbiological tests of large numbers of contemporary clinical isolates, the compound has been shown to be at least 32-fold more potent than levofloxacin, ciprofloxacin, gatifloxacin and moxifloxacin against quinolone-resistant MRSA (MIC90 of = 0.5 ug/ml for delafloxacin compared to > 16 ug/ml for all other quinolones) and twice as potent as daptomycin against MRSA. Additionally, delafloxacin was shown to more potent than ciprofloxacin against N. gonorrhoeae (MIC90 of = 0.06 ug/ml for delafloxacin compared to > 16 ug/ml for ciprofloxacin). Delafloxacin has also been shown to be more potent than existing quinolones against a range of Gram-positive, anaerobic and Gram-negative organisms. Rib-X is currently developing both IV and oral formulations of delafloxacin for use in surgical prophylaxis and other therapeutic arenas within the over $9.9 billion hospital antibiotic market.

About Rib-X Pharmaceuticals, Inc.

Rib-X Pharmaceuticals, Inc. is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The Company's underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the ribosome, which performs an essential role in protein synthesis. Many known, commercially valuable antibiotics exert their effects by binding to the bacterial ribosome. The Compa
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
2. Rib-X Granted Key Antibiotic Patent in China
3. Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
4. Rib-X CEO Susan Froshauer, PhD, Honored by The Connecticut Womens Hall of Fame
5. Merz Pharmaceuticals Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA
6. Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States
7. Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
8. Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
9. Reportlinker Adds US and European Radiopharmaceuticals Market Report
10. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
11. Isis Pharmaceuticals to Present at Morgan Stanleys Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 In God’s Unstoppable Favor, ... as she writes an unforgettable story of how God ... life. The first black student to desegregate Evangeline Parish ... by some students, treated harshly by a few teachers, ... personal phone conversation with Dr. Martin Luther King, Jr. ...
(Date:5/26/2015)... 26, 2015 Dermatologic surgeons performed nearly ... according to survey results released today by the American ... cancer treatments and several cosmetic categories, 2014 totals were ... steady overall compared to 2013 figures. , For ... ranked as the most-performed procedure (3.08 million) by ASDS ...
(Date:5/26/2015)... York (PRWEB) May 26, 2015 The ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who were ... the litigation’s June 11th Science Day. According to an ... of Louisiana, on May 21st, topics to be addressed ... drug, the use of blood test based testing with ...
(Date:5/26/2015)... Rochester, MN (PRWEB) May 26, 2015 ... years of debilitating nosebleeds and fainting spells, four of ... even leading to cardiac arrest. , Though she ... transfusion, she continues to dedicate her time to increasing ... mission. , “Had there been awareness, we could have ...
(Date:5/26/2015)... May 26, 2015 Last week, ... Mexico patients with MRI, Ultrasound, and CT services—was ... American College of Radiology. The center is now ... , In order to be eligible for ... of qualifications including personnel qualifications, adequacy of facility ...
Breaking Medicine News(10 mins):Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4Health News:Rochester Woman Brings Awareness to Genetic Disease 2
... N.C. A molecular recycling plant permits nerve cells ... functions changeable enough to record new experiences, yet ... The discovery of this molecular recycling plant, detailed in ... journal Neuron, provides new insights into how the basic ...
... Lester, M.D., was faced with a dilemma: seven patients ... may or may not help them, and not enough ... Dr. Lester devised what he called a simple-minded experiment ... microarray chips, Dr. Lester analyzed his patients tumors for ...
... Following the,successful OCEANE bond issue, completed last ... million, Quantel signed on September 18th a,definitive agreement ... Aesthetic GmbH, its subsidiary specialized in,dermatology-aesthetics lasers. ... includes a EUR4.6 million fixed portion and a,variable ...
... Judge Patrick Brady,of Norfolk County, Massachusetts Superior ... for a preliminary injunction that would have given ... milk during the national,medical licensing examination. According ... not agree that,refusal to permit additional break time ...
... The National Retail,Federation welcomed last night,s Senate ... House subcommittee to adopt the Senate,s version,when the ... "The Senate bill is a strong measure ... balancing the interests of employers," said NRF Vice,President ...
... feet, legs may have spurred Homo ,s spread, experts ... came to spreading across the globe, humanity,s early ancestors may ... paleontologists examining the partial skeletons of a group of four ... Georgia nearly 1.8 million years ago. , Their remains -- ...
Cached Medicine News:Health News:New understanding of basic units of memory 2Health News:Gene chip data improved therapy in some patients with incurable cancer 2Health News:Gene chip data improved therapy in some patients with incurable cancer 3Health News:QUANTEL Finalizes the Acquisition of WaveLight Aesthetic GmbH 2Health News:Mass. Judge Denies Request by Breastfeeding Mother for More Break Time on Medical Licensing Exam 2Health News:Retailers Welcome Senate Passage of Mental Health Parity Bill, Urge House to Adopt Senate Version at Subcommittee Markup 2Health News:Early Human-Like Skeletons Are First Outside of Africa 2Health News:Early Human-Like Skeletons Are First Outside of Africa 3
(Date:5/26/2015)... , May 26, 2015 Aethlon Medical, ... therapeutic devices to address infectious diseases and cancer, ... Chief Executive Officer, will present at the SeeThruEquity ... 28th.  Details of Aethlon Medical,s presentation are as ... Date: , Thursday, May 28, 2015Time: , 8:00 ...
(Date:5/26/2015)... LONDON , May 26, 2015 ... Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma ... dolutegravir 50mg, for Tentative Approval, to the Food and ... is the first ANDA for a generic version of ... Tivicay® (dolutegravir) for sale in the United ...
(Date:5/26/2015)... Mass. , May 26, 2015  Respiratory ... 62 nd Annual Meeting of the Japanese ... of monitoring patient respiration in hospitals miss critical ... risks to patients. The findings conclude that respiratory ... Respiratory Motion, Inc. more consistently protects patients than ...
Breaking Medicine Technology:Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... Patient Safety Technologies, Inc. (the "Company") (OTCBB: PSTX) today ... and Chief Financial Officer.  Mr. Dreyer will be responsible ... Company and its wholly-owned operating subsidiary, SurgiCount Medical, as ... initiatives and operational improvements. "We are pleased ...
... Oct. 27 Recognizing the innovative ideas of today,s ... program of Invent Now, today announced that a way ... drug testing and a way to manufacture composite structural ...  Alice Chen of the Harvard/MIT Health Sciences and Technology ...
Cached Medicine Technology:Patient Safety Technologies Appoints New Chief Financial Officer 2Winners Announced in 2010 Collegiate Inventors Competition® 2Winners Announced in 2010 Collegiate Inventors Competition® 3Winners Announced in 2010 Collegiate Inventors Competition® 4Winners Announced in 2010 Collegiate Inventors Competition® 5
36" Penrose drains...
12" Penrose drains...
Offers a more constant suction profile than three-spring evacuators, resulting in the potential for improved tissue approximation and reduced risk of hematoma....
Reliavac® 400cc kits with flat drain, Y-connector tubing...
Medicine Products: